Патологические переломы, осложняющие остеопороз
Клинические рекомендации
Management of aromatase inhibitor-associated bone loss (AIBL) in women with hormone-sensitive breast cancer: An updated joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG
2024
The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)https://www.esceo.org/
Recommendations for the optimal use of bone forming agents in osteoporosis
Goal-directed osteoporosis treatment: ASBMR/BHOF task force position statement 2024